Literature DB >> 19647485

Post-cardiac injury syndrome following transvenous pacemaker insertion: A case report and review of the literature.

Cihan Cevik1, Troy Wilborn, Rita Corona, Elizabeth Schanzmeyer, Kenneth Nugent.   

Abstract

Post-cardiac injury syndrome is an inflammatory process involving the pleura and pericardium secondary to cardiac injury and can develop following transvenous pacemaker insertion. We now report a patient who developed this syndrome following dual-chamber pacemaker insertion with active fixation of the atrial and ventricular leads. The pericardial fluid was bloody and had a neutrophilic predominance. The pericardial biopsy revealed fibrinous pericarditis with a mixed inflammatory cell infiltrate. The pleural effusion was exudative and had a neutrophilic predominance. Nine similar cases were identified in the English literature dating back to 1975. These patients usually present within one month after pacemaker insertion. They have exudative pericardial and pleural effusions. The pericardial effusions can cause tamponade and may require treatment with either catheter drainage or a surgical window. Some of these patients respond well to anti-inflammatory medications, including prednisone. Therefore, early identification of these patients could allow medical treatment and might help avoid the need for a surgical procedure. Cardiologists should remember that this uncommon syndrome can occur after routine endovascular procedures.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19647485     DOI: 10.1016/j.hlc.2009.04.001

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  9 in total

1.  The return of a disappearing entity: Dressler's syndrome after transvenous pacemaker implantation.

Authors:  António Tralhão; Diogo Cavaco; Marisa Trabulo; António M Ferreira
Journal:  BMJ Case Rep       Date:  2014-03-20

2.  Massive ascites generation following pacemaker infection: a case report.

Authors:  Uwe Raaz; Michael Buerke; Dietrich Stoevesandt; Philipp Thermann; Ivar Friedrich; Axel Schlitt; Henning Ebelt; Ursula Müller-Werdan; Rainer Rienmüller; Rolf-Edgar Silber; Karl Werdan
Journal:  Clin Res Cardiol       Date:  2011-06-24       Impact factor: 5.460

Review 3.  Post cardiac injury syndrome after initially uncomplicated CRT-D implantation: a case report and a systematic review.

Authors:  Farbod Sedaghat-Hamedani; Edgar Zitron; Elham Kayvanpour; Hanns-Martin Lorenz; Hugo A Katus; Benjamin Meder
Journal:  Clin Res Cardiol       Date:  2014-04-29       Impact factor: 5.460

Review 4.  New Insights into Pericarditis: Mechanisms of Injury and Therapeutic Targets.

Authors:  Bo Xu; Serge C Harb; Paul C Cremer
Journal:  Curr Cardiol Rep       Date:  2017-07       Impact factor: 2.931

5.  Low interleukin-8 level predicts the occurrence of the postpericardiotomy syndrome.

Authors:  Maria Jaworska-Wilczyńska; Adriana Magalska; Katarzyna Piwocka; Piotr Szymański; Mariusz Kuśmierczyk; Maria Wąsik; Tomasz Hryniewiecki
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

6.  Colchicine reduced pericardial effusion due to postcardiac injury syndrome following cardiac resynchronization therapy implantation.

Authors:  Tadashi Hoshiyama; Keiichi Ashikaga; Kenichi Tsujita; Yoshisato Shibata
Journal:  Clin Case Rep       Date:  2017-05-10

7.  Prevalence, Predictors, and Clinical Presentation of Acute Pericardial Effusion Following Percutaneous Coronary Intervention.

Authors:  Bei Zhao; Jie Zhang; Yun Li; Xueyao Feng; Shuai Mao; Zhao Yin; Li Liu; Dapeng Song; Shouli Wang
Journal:  Front Cardiovasc Med       Date:  2022-01-11

8.  Post-cardiac Injury Syndrome Following Permanent Dual-Chamber Pacemaker Implantation.

Authors:  Zeel K Patel; Meet S Shah; Ronak Bharucha; Michael Benz
Journal:  Cureus       Date:  2022-01-30

9.  Pericarditis-induced hyponatremia after cardiac electronic implantable device (CEID) procedures.

Authors:  Elnaz Rakhshan; Seyed Abbas Mirabbasi; Bahar Khalighi; Koroush Khalighi
Journal:  Am J Case Rep       Date:  2015-04-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.